Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

This article is part of the supplement: Proceedings of the 8th Global Arthritis Research Network (GARN) Meeting and 1st Bio-Rheumatology International Congress (BRIC)

Poster presentation

Resistance to morphine analgesia and its underlying mechanisms in an experimental mouse model of fibromyalgia

Hitoshi Uchida*, Michiko Nishiyori and Hiroshi Ueda

  • * Corresponding author: Hitoshi Uchida

Author Affiliations

Division of Molecular Pharmacology and Neuroscience, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8521, Japan

For all author emails, please log on.

Arthritis Research & Therapy 2012, 14(Suppl 1):P71  doi:10.1186/ar3672


The electronic version of this article is the complete one and can be found online at: http://arthritis-research.com/content/14/S1/P71


Published:9 February 2012

© 2012 Uchida et al.; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Poster presentation

Fibromyalgia (FM) is a common condition with generalized or widespread allodynia that affects at least 2% of the US, European and Japanese populations. Although the etiology of this disease remains poorly understood, physical and psychological stressors have been assumed to play a role in the development of FM. Previously, we have established an experimental mouse model of FM pain, using intermittent cold stress (ICS) exposure. This model was found to produce mechanical allodynia and thermal hyperalgesia in a female-predominant manner, as often observed in FM patients. In contrast, exposure to constant cold stress produced a transient allodynia. Importantly, we found that anticonvulsant agent gabapentin, especially when injected intracerebroventricularly, exerts powerful anti-allodynic and anti-hyperalgesic effects in the ICS-exposed mice. In this study, we found that ICS model mice show morphine resistance, as often observed in FM patients. To be concrete, systemic or intracerebroventricular, but not intrathecal or intraplantar, injection of morphine caused no significant analgesia in the ICS-exposed mice. In addition, we found that intracerebroventricularly administrated morphine increases the 5-hydroxytryptamine turnover ratio in the dorsal half of the spinal cord of control mice, but not in the ICS-exposed mice. These findings indicate that ICS model well reflects pathological and pharmacotherapeutic features of FM pain, and the loss of descending serotonergic activation seems to be a crucial mechanism underlying the absence of morphine-induced analgesia in the ICS model.

References

  1. Nishiyori M, Ueda H: Prolonged gabapentin analgesia in an experimental mouse model of fibromyalgia.

    Mol Pain 2008, 4:52. PubMed Abstract | BioMed Central Full Text | PubMed Central Full Text OpenURL

  2. Nishiyori M, Nagai J, Nakazawa T, Ueda H: Absence of morphine analgesia and its underlying descending serotonergic activation in an experimental mouse model of fibromyalgia.

    Neurosci Lett 2010, 472:184-187. PubMed Abstract | Publisher Full Text OpenURL